HIV Research Enterprise Blog Series

Measuring Innovation: Laboratory Infrastructure to Deliver Essential HIV Clinical Trial Results

HIV clinical trials network laboratory functions will continue to evolve to align with scientific priorities and research approaches.

Shaping the Next Era of HIV Therapeutics and Care

The Institute aims to foster the next generation of discoveries that will enable people with HIV to experience a typical lifespan with high life quality. Scientific priorities include removing the chronic HIV medication burden; reducing the incidence of concurrent TB and hepatitis; and ensuring scientific advances can feasibly be scaled to all who stand to benefit.

Defining the Goals of HIV Science Through 2034

Discovery, Development and Delivery for an Increasingly Interconnected HIV Landscape

By Carl Dieffenbach, Ph.D., director, Division of AIDS, NIAID

We envision an HIV research enterprise that follows a logical evolution in addressing new scientific priorities informed by previous research progress. We will fund our next networks to align with updated research goals…

Bringing HIV Study Protocols to Life with Representative, High-Quality Research

The HIV clinical trials network sites have made tremendous contributions to NIH’s scientific priorities by offering direct access to and consultation with populations most affected by HIV globally, and by delivering high-quality clinical research with strong connections to trusted community outreach platforms. Future networks will need to maintain core strengths of current models while expanding…

Charting the Path to an HIV-Free Generation

NIAID supports four research networks as part of its HIV clinical research enterprise. Every seven years, the Institute engages research partners, community representatives, and other public health stakeholders in a multidisciplinary evaluation of network progress toward short- and long-term scientific goals. Pregnancy, childbirth and the postnatal period are a key focus of NIAID HIV research and…